Skip to main content
. 2023 Dec 18;24:976. doi: 10.1186/s12891-023-07096-0

Table 3.

Characteristics of Survey Responders Grouped by Race/Ethnicitya

Overall Race Category Significance Test*
Cohort
N = 738
Black (B)
N = 76
White (W)
N = 556
Hispanic (H)
N = 64
p-value
Sociodemographic variables
Age, years (mean, SD) 59.3 (10.8) 59.9 (13.4) 59.8 (10.2) 53.7 (9.8) < 0.01
Female (%) 88.0 90.8 87.9 87.3
Education level (%)
Some high school 8.9 14.5 5.9 20.3 < 0.01
Some college 37.7 51.3 35.3 34.4
College graduate 53.5 34.2 58.0 45.3
Insurance statusb (%)
Medicare 46.2 50.0 48.8 32.8 < 0.01
Medicaid 18.2 27.6 16.9 20.3
Private 49.3 40.8 51.4 53.1
Uninsured 4.9 7.9 3.4 10.9
Pain and disability attributed to arthritis (mean, SD)
Pain in hip/knee (Y/N) (%) 96.9 93.4 97.5 93.8 < 0.1
Pain VAS (0–100) (0–100) 61.5 (23.0) 65.7 (28.5) 60.5 (21.9) 60.6 (24.7) < 0.05
HOOS, JR (0–24) 58.9 (23.9) 61.3 (28.1) 59.6 (20.0) 55.2 (23.9) < 0.1
KOOS, JR (0–26) 51.7 (20.3) 50.3 (25.3) 52.7 (19.8) 49.0 (18.8) < 0.05
Providers seen to evaluate arthritis (%)
Primary care physician 48.0 39.5 51.8 42.2 < 0.01
Orthopedist 47.6 56.6 48.9 35.9 < 0.05
Rheumatologist 57.7 31.6 60.6 67.2 < 0.01
No one 4.6 5.3 4.7 6.3
Other 8.3 10.5 7.9 7.8
Discussed arthroplasty with provider 51.4 65.8 52.5 29.7 < 0.01
Treatments tried for arthritis (%)
Over the counter medication 81.8 72.4 85.6 70.3 < 0.01
Physical therapy 61.8 61.8 63.5 53.1
Acupuncture 15.0 10.5 15.7 14.1
Braces 24.5 23.7 25.5 20.3
Joint injection 59.8 51.3 63.5 43.75 < 0.01
Topical creams/salves 64.9 56.6 67.3 67.2
Prescription medication 75.9 65.8 77.2 81.3 < 0.1
Other 10.7 4.0 11.3 14.1
None 2.6 5.3 2.3 3.1

*Significance tests are Chi-square/Fisher’s exact tests comparing all race categories (Black, White, Hispanic)

aUnless otherwise stated, all values presented represent the percentage of participants per variable

bPatients can be on multiple insurance categories